Skip to product information
1 of 1

GeneBio Systems

Recombinant Human Mesothelin/MSLN Protein (His & Avi Tag)

Recombinant Human Mesothelin/MSLN Protein (His & Avi Tag)

SKU:PKSH033798

Regular price $1,476.00 CAD
Regular price Sale price $1,476.00 CAD
Sale Sold out
Shipping calculated at checkout.

Size: 100μg

Storage: Generally, lyophilized proteins are stable for up to 12 months when stored at -20 to -80℃. Reconstituted protein solution can be stored at 4-8℃ for 2-7 days. Aliquots of reconstituted samples are stable at < -20℃ for 3 months.

Shipping: This product is provided as lyophilized powder which is shipped with ice packs.

Exp date: 12 months

Category ID_II: Recombinant Proteins

Category ID_III: Others

Abbreviation: Mesothelin;MSLN

Target Synonym: CAK1;CAK1 antigen;MPF;MSLN;Megakaryocyte potentiating factor;Pre-pro-megakaryocyte-potentiating factor;SMR;mesothelin;soluble MPF mesothelin related protein

Research Areas: Tags & Cell Markers,Cancer

Conjugation: Biotinylated

Target Species: Human

Expression Host: HEK293 Cells

Application:

Fusion tag: C-His-Avi

UNIProt ID: Q13421

Accession: AAH09272.1

Background: Mesothelin is a cell surface glycoprotein whose expression is limited to mesothelial cells of the serosa (pleura, pericardium, and peritoneum) and epithelial cells of the trachea, tonsils, fallopian tube, and kidneys. Mesothelin plays an important role in cell survival, proliferation, migration, invasion, tumor progression, and resistance to chemotherapy. The overexpression of mesothelin can activate NF-κB and signal transducer and activator of transcription 3 (Stat3), inhibit apoptotic signaling and TNF-α-induced apoptosis, and accelerate the G1–S transition. Mesothelin is also found overexpressed in various cancers, including malignant mesothelioma, pancreatic or ovarian carcinoma, sarcomas and in some gastrointestinal or pulmonary carcinomas. As a result of its limited expression in normal tissues, mesothelin has been reported as an ideal tumor-associated marker for the development of targeted therapy.

Concentration:

Activity: Not validated for activity

Sequence: Glu296-Ser598

Purity: > 95 % as determined by reducing SDS-PAGE.

Formulation: Lyophilized from a 0.2 μm filtered solution of PBS, pH 7.4.
Normally 5% - 8% trehalose, mannitol and 0.01% Tween 80 are added as protectants before lyophilization.
Please refer to the specific buffer information in the printed manual.

Reconstitution: Please refer to the printed manual for detailed information.

Endotoxin: < 1.0 EU per μg of the protein as determined by the LAL method.

Calculated MW: 36.7 kDa

ObservedMW: 38-60 kDa

View full details